Low-level gains in the GLI1 genomic region have been noted in ERMS patients.5 The expression of GLI target genes, which include components of the hedgehog pathway such as GLI1, PTCH1 and HHIP, can be used to study pathway activation status.8, 9. This evidence concerns the gene GLI1 and embryonal rhabdomyosarcoma.